Saturday, July 11, 2026

pharma · Influenza · Encephalitis, Japanese B

Repatha

Repatha clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

JP HQ
PMDA registrant Type
Company details
Status
Public
HQ
JP
Programs
3
Drugs
6
Patents
0
Intelligence · Clinical Programs

Repatha projects

1 ClinicalTrials.gov programs sponsored by Repatha.

Repatha has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Live attenuated SA 14-14-2 vaccine

    Repatha

    Encephalitis, Japanese B

    phase 3 mab completed

    1 trial

Frequently asked questions

How many clinical projects does Repatha have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.